You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 111 No. 1, January 1993 TABLE OF CONTENTS
  Archives
  •  Online Features
  EPIDEMIOLOGY AND BIOSTATISTICS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Randomized Clinical Trials on Medical Treatment of Glaucoma

Are They Appropriate to Guide Clinical Practice?

Luca Rossetti, MD; Ilaria Marchetti, MD; Nicola Orzalesi, MD; Nicola Scorpiglione, MD; Valter Torri, MD; Alessandro Liberati, MD

Arch Ophthalmol. 1993;111(1):96-103.


Abstract

• A systematic quantitative and qualitative overview of published randomized clinical trials was undertaken to assess the yield of medical treatment on the outcome of patients with primary open angle glaucoma. Reports of 102 randomized clinical trials were published between 1975 and 1991, totaling about 5000 patients. Only 16% (16/102) of the trials were, however, properly designed (ie, comparing an active treatment with a placebo-treated or untreated control group) to answer the question of whether any medical treatment can effectively cure patients with primary open angle glaucoma. Pooled analysis showed a moderate yet statistically significant reduction in mean intraocular pressure (–4.9 mm Hg; 95% confidence interval [Cl], –7.3 to –2.5 mm Hg); however, data on long-term visual field changes were available in only three randomized clinical trials, and their statistical combination failed to show a significant protective effect of active treatment (odds ratio, 0.75; 95% CI, 0.42 to 1.35). All of the remaining 86 randomized clinical trials looked at the effectiveness of one drug vs another in lowering intraocular pressure and were thus of no use in the overview. Practicing ophthalmologists should be aware that the effectiveness of pressure-lowering agents in the treatment of primary open angle glaucoma is still to be determined and that the vast majority of published trials are not appropriate to guide clinical practice. It is urgent to plan trials with end-point and follow-up duration that is fully relevant for the health of patients.



Author Affiliations

From the Eye Clinic, University of Milan, Institute of Biomedial Science, S. Pãolo Hospital (Drs Rossetti, Marchetti, and Orzalesi) and the Laboratory of Clinical Epidemiology (Centro "Catullo e Daniela Borgomainerio"), Mario Negri Institute (Drs Rossetti, Torri, and Liberati), Milan, Italy; and the Laboratory of Pharmacology and Clinical Epidemiology, Consorzio Mario Negri Sud, S. Maria Imbaro, Chieti, Italy (Dr Scorpiglione).


Footnotes

Accepted for publication April 24, 1992.

Reprint requests to Laboratorio di Epidemiologia Clinica, Centro "Catullo e Daniela Borgomainerio," Istituto di Ricerche Farmacologiche Mario Negri, Via Eritrea 62, 20157 Milano, Italia (Dr Liberati).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trials
Maier et al.
BMJ 2005;331:134.
ABSTRACT | FULL TEXT  

Treatment of raised intraocular pressure and prevention of glaucoma
Wormald
BMJ 2003;326:723-724.
FULL TEXT  

Factors for Glaucoma Progression and the Effect of Treatment: The Early Manifest Glaucoma Trial
Leske et al.
Arch Ophthalmol 2003;121:48-56.
ABSTRACT | FULL TEXT  

Reduction of Intraocular Pressure and Glaucoma Progression: Results From the Early Manifest Glaucoma Trial
Heijl et al.
Arch Ophthalmol 2002;120:1268-1279.
ABSTRACT | FULL TEXT  

The Ocular Hypertension Treatment Study: A Randomized Trial Determines That Topical Ocular Hypotensive Medication Delays or Prevents the Onset of Primary Open-Angle Glaucoma
Kass et al.
Arch Ophthalmol 2002;120:701-713.
ABSTRACT | FULL TEXT  

Non-penetrating glaucoma surgery: the state of play
TAN and HITCHINGS
Br J Ophthalmol 2001;85:234-237.
FULL TEXT  

The Ocular Hypertension Treatment Study: Design and Baseline Description of the Participants
Gordon et al.
Arch Ophthalmol 1999;117:573-583.
ABSTRACT | FULL TEXT  

Evidence based medicine, the Cochrane Collaboration, and the CONSORT statement
WORMALD and OLDFIELD
Br J Ophthalmol 1998;82:597-598.
FULL TEXT  

Randomized Clinical Trials on Medical Treatment of Glaucoma: Are They Appropriate to Guide Clinical Practice?
Novack and Robin
Arch Ophthalmol 1994;112:726-726.
ABSTRACT  

Randomized Clinical Trials on Medical Treatment of Glaucoma: Are They Appropriate to Guide Clinical Practice?-Reply
Rossetti et al.
Arch Ophthalmol 1994;112:727-728.
ABSTRACT  

Randomized Clinical Trials on Medical Treatment of Glaucoma: Are They Appropriate to Guide Clinical Practice?
Vogel and Strahlman
Arch Ophthalmol 1994;112:726-727.
ABSTRACT  

The Medical Treatment of Open-Angle Glaucoma
Rossetti et al.
NEJM 1993;329:735-736.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.